Scopri l'ERA Neph-Manual Il nostro nuovo beneficio per supportare la formazione dei giovani nefrologi Scopri di più
Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European Renal Best Practice board of the European Renal Association Aprile 04, 2024 ERBP
SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease Ottobre 20, 2023 ERBP
Chronic kidney disease: the missing concept in the 2019 EULAR/ERA-EDTA recommendations for lupus nephritis Luglio 11, 2023 ERBP
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) Giugno 24, 2023 ERBP
SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EuReCa-M and ERBP working groups of ERA Maggio 25, 2023 ERBP
Atherosclerotic Renovascular Disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH) Maggio 18, 2023 ERBP
Alignment and Synergy in Long-Term Vision: A Memorandum of Understanding between the European Renal Association and the Kidney Disease Improving Global Outcomes Aprile 11, 2023 ERBP
A European Renal Best Practice (ERBP) endorsement of ISTH Guidelines for Treatment of Thrombotic Thrombocytopaenic Purpura (TTP) with some refinements for Europe. Febbraio 23, 2023 ERBP